title: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.
abstract: Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
authors.affiliation: Wyeth-Ayerst Research, Pearl River, NY 10965, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Shlaes
authors.forename: D N
authors.initials: DN
authors.lastname: Gerding
authors.forename: J F
authors.initials: JF
authors.lastname: John
authors.forename: W A
authors.initials: WA
authors.lastname: Craig
authors.forename: D L
authors.initials: DL
authors.lastname: Bornstein
authors.forename: R A
authors.initials: RA
authors.lastname: Duncan
authors.forename: M R
authors.initials: MR
authors.lastname: Eckman
authors.forename: W E
authors.initials: WE
authors.lastname: Farrer
authors.forename: W H
authors.initials: WH
authors.lastname: Greene
authors.forename: V
authors.initials: V
authors.lastname: Lorian
authors.forename: S
authors.initials: S
authors.lastname: Levy
authors.forename: J E
authors.initials: JE
authors.lastname: McGowan
authors.forename: S M
authors.initials: SM
authors.lastname: Paul
authors.forename: J
authors.initials: J
authors.lastname: Ruskin
authors.forename: F C
authors.initials: FC
authors.lastname: Tenover
authors.forename: C
authors.initials: C
authors.lastname: Watanakunakorn
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000472:pathogenicity; D018407:Bacterial Physiological Phenomena; D003428:Cross Infection / Q000503:physiopathology / Q000517:prevention & control* / Q000635:transmission; D004352:Drug Resistance, Microbial / Q000235:genetics; D006801:Humans; D017053:Infection Control / Q000592:standards*; D017146:Models, Organizational; D016134:Organizational Policy; D010356:Patient Isolation / Q000592:standards; D012955:Societies, Medical / Q000592:standards*; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents